Skip to the page

Data / Form D filings / Ubicept, Inc.

Ubicept, Inc.: Form D filings

Ubicept, Inc., a company in Boston, MA, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on June 24, 2025, reports $4.6 million sold of a $5 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
55 COURT STREET, Boston, MA, 02108
Phone
(617) 383-9704
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1986281

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 24, 2025New notice$4,999,992$4,620,993$378,9999Jun 10, 2025sec.gov
Jul 27, 2023New notice$7,814,999$7,814,99916May 16, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Craig DickmanDirector
Tristan SwedishExecutive Officer, Director
Sebastian BauerExecutive Officer, Director

Other companies in Massachusetts that filed recently

Every Form D from the week of Jun 23, 2025 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Ubicept, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.